Overexpression of ANXA1 in Penile Carcinomas Positive for High-Risk HPVs
Carregando...
Citações na Scopus
19
Tipo de produção
article
Data de publicação
2013
Editora
PUBLIC LIBRARY SCIENCE
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
CALMON, Marilia Freitas
MOTA, Manlio Tasso de Oliveira
BABETO, Erica
CANDIDO, Natalia Maria
GIROL, Ana Paula
MENDIBURU, Carlos Fabian
BONILHA, Jane Lopes
SILVESTRE, Rodrigo Vellasco Duarte
ROSA, Bruno Miziara
THOME, Jorge Alberto
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
PLOS ONE, v.8, n.1, article ID e53260, 7p, 2013
Resumo
The incidence of penile cancer varies between populations but is rare in developed nations. Penile cancer is associated with a number of established risk factors and associated diseases including phimosis with chronic inflammation, human papillomavirus (HPV) infection, poor hygiene and smoking. The objective of this study was to identify genes related to this type of cancer. The detection of HPV was analyzed in 47 penile squamous cell carcinoma samples. HPV DNA was detected in 48.9% of penile squamous cell carcinoma cases. High-risk HPV were present in 42.5% of cases and low-risk HPV were detected in 10.6% of penile squamous cell carcinomas. The RaSH approach identified differential expression of Annexin A1 (ANXA1), p16, RPL6, PBEF1 and KIAA1033 in high-risk HPV positive penile carcinoma; ANXA1 and p16 were overexpressed in penile squamous cells positive for high-risk HPVs compared to normal penile samples by qPCR. ANXA1 and p16 proteins were significantly more expressed in the cells from high-risk HPV-positive penile carcinoma as compared to HPV-negative tumors (p<0.0001) independently of the subtype of the carcinoma. Overexpression of ANXA1 might be mediated by HPV E6 in penile squamous cell carcinoma of patients with high-risk HPVs, suggesting that this gene plays an important role in penile cancer.
Palavras-chave
Referências
- Ahn SH, 1997, CLIN EXP METASTAS, V15, P151, DOI 10.1023/A:1018452810915
- Alldridge LC, 1999, J BIOL CHEM, V274, P37620, DOI 10.1074/jbc.274.53.37620
- Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
- [Armed Forces Institute of Pathology (U.S.) National Research Council (U.S.)], ATLAS TUMOR PATHOLOG
- Backes DM, 2009, CANCER CAUSE CONTROL, V20, P449, DOI 10.1007/s10552-008-9276-9
- Bai XF, 2004, WORLD J GASTROENTERO, V10, P1466
- Barnholtz-Sloan JS, 2007, UROL ONCOL-SEMIN ORI, V25, P361, DOI 10.1016/j.urolonc.2006.08.029
- Begum S, 2007, CLIN CANCER RES, V13, P1186, DOI 10.1158/1078-0432.CCR-06-1690
- Bleeker MCG, 2009, WORLD J UROL, V27, P141, DOI 10.1007/s00345-008-0302-z
- Calmon MF, 2009, NEOPLASIA, V11, P1329, DOI 10.1593/neo.91110
- Calmon MF, 2011, THESCIENTIFICWORLDJO, V11, P269, DOI 10.1100/tsw.2011.24
- Cubilla AL, 2011, AM J SURG PATHOL, V35, P253, DOI 10.1097/PAS.0b013e318203cdba
- HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057
- de Coupade C, 2000, HEPATOLOGY, V31, P371, DOI 10.1002/hep.510310217
- Dorovkov MV, 2004, J BIOL CHEM, V279, P50643, DOI 10.1074/jbc.C400441200
- Edge SB, 2010, AJCC CANC STAGING MA
- Favorito LA, 2008, INT BRAZ J UROL, V34, P587, DOI 10.1590/S1677-55382008000500007
- Ferrandiz-Pulido C, 2012, J AM ACAD DERMATOL
- Ferreux E, 2003, J PATHOL, V201, P109, DOI 10.1002/path.1394
- Fregonesi PAG, 2003, J HISTOCHEM CYTOCHEM, V51, P1291
- Pedrero JMG, 2004, AM J PATHOL, V164, P73
- Hannon Robert, 2003, FASEB Journal, V17, P253
- Hippo Y, 2001, CANCER RES, V61, P889
- Howie HL, 2009, VIROLOGY, V384, P324, DOI 10.1016/j.virol.2008.11.017
- Hu N, 2004, CLIN CANCER RES, V10, P6013, DOI 10.1158/1078-0432.CCR-04-0317
- HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P4918
- JOHNSON MD, 1989, HUM PATHOL, V20, P772, DOI 10.1016/0046-8177(89)90071-3
- KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634
- Kang JS, 2002, CLIN CANCER RES, V8, P117
- Lu DW, 2003, MODERN PATHOL, V16, P692, DOI 10.1097/01.MP.0000077417.08371.CE
- Masaki T, 1996, HEPATOLOGY, V24, P72, DOI 10.1002/hep.510240114
- Miralles-Guri C, 2009, J CLIN PATHOL, V62, P870, DOI 10.1136/jcp.2008.063149
- Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886
- Nam Eun Ji, 2008, J Gynecol Oncol, V19, P162, DOI 10.3802/jgo.2008.19.3.162
- Nam EJ, 2007, GYNECOL ONCOL, V104, P207, DOI 10.1016/j.ygyno.2006.07.043
- Nguyen M, 2002, J VIROL, V76, P13039, DOI 10.1128/JVI.76.24.13039-13048.2002
- Paschalidis N, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-33
- Paweletz CP, 2000, CANCER RES, V60, P6293
- Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
- Protzel C, 2011, WORLD J UROL, V29, P393, DOI 10.1007/s00345-010-0575-x
- Prowse DM, 2008, BRIT J DERMATOL, V158, P261, DOI 10.1111/j.1365-2133.2007.08305.x
- Raiol T, 2011, INTERVIROLOGY, V54, P146, DOI 10.1159/000320199
- Rodrigo JP, 2005, AM J RHINOL, V19, P483
- Senba M, 2009, ACTA VIROL, V53, P43, DOI 10.4149/av_2009_01_43
- Shen DJ, 2006, HUM PATHOL, V37, P1583, DOI 10.1016/j.humpath.2006.06.001
- Shimoji T, 2009, J CELL BIOCHEM, V106, P1123, DOI 10.1002/jcb.22096
- Shirakura M, 2007, J VIROL, V81, P1174, DOI 10.1128/JVI.01684-06
- Silistino-Souza R, 2007, INT J CANCER, V120, P2582, DOI 10.1002/ijc.22639
- SLEBOS RJC, 1994, P NATL ACAD SCI USA, V91, P5320, DOI 10.1073/pnas.91.12.5320
- Song SY, 1999, J VIROL, V73, P5887
- Tewari M, 2007, ASIAN J SURG, V30, P126, DOI 10.1016/S1015-9584(09)60145-7
- Thomas M, 2008, ONCOGENE, V27, P7018, DOI 10.1038/onc.2008.351
- Villota C, 2012, J BIOL CHEM, V287, P21303, DOI 10.1074/jbc.M111.326694
- Xia SH, 2002, ONCOGENE, V21, P6641, DOI 10.1038/sj.onc.1205818
- Xin W, 2003, AM J PATHOL, V162, P255, DOI 10.1016/S0002-9440(10)63816-3
- Yi M, 2009, P NATL ACAD SCI USA, V106, P17886, DOI 10.1073/pnas.0901324106